MedPath

Rapid sequence induction in patients with esophageal achalasia: remimazolam vs propofol

Not Applicable
Suspended
Conditions
esophageal achalasia
Registration Number
JPRN-UMIN000044837
Lead Sponsor
Showa University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Suspended
Sex
All
Target Recruitment
40
Inclusion Criteria

Not provided

Exclusion Criteria

1) allergy to benzodiazepine, propofol, inhalation anesthetics, or soybeans 2) history or family history of malignant hyperthermia 3) chronic intake of benzodiazepine 4) pregnancy 5) neurological disorders that may affect the electroencephalographic waveform 6) American Society of Anesthesiologist physical status 3 or above 7) patients who have been judged ineligible by the anesthesiologists in charge of the study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath